🔗 Permalink

Inventor profile of:

Ravindra Kumar

City:

Acton, Massachusetts

Country:

United States

Published Applications:

175

Last publication date:

2026-05-14

Top Assignees for applications by Ravindra Kumar

The entities that hold a legal rights for patent applications filed by inventor Kumar Ravindra:

Acceleron Pharma, Inc. 116 Cambridge, MA United States
Acceleron Pharma Inc. 6 Rahway, NJ United States
Wyeth 5 Madison, NJ United States
Ludwig Institute for Cancer Research Ltd. 5 New York, NY United States
GENETICS INSTITUTE, LLC 3 Cambridge, MA United States
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 3 Boston, MA United States
DYAX CORP. 1 Burlington, MA United States
THE REGENTS OF THE UNIVERSITY OF MICHIGAN 1 Ann Arbor, MI United States
The Bringham and Women's Hospital, Inc. 1 Boston, MA United States
DYAX CORPORATION 1 Burlington, MA United States
ACCLERON PHARMA INC. 1 Cambridge, MA United States

Recent patent applications by Kumar Ravindra

Ravindra Kumar from Acton, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-14

US20260132207A1

Chemistry; metallurgy

ACTIVIN TYPE 2 RECEPTOR BINDING PROTEINS AND USES THEREOF

#2 | 2025-07-10

US20250222069A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING MYELOFIBROSIS

#3 | 2025-04-03

US20250109179A1

Chemistry; metallurgy

MULTISPECIFIC BINDERS OF TGFBeta-SUPERFAMILY LIGANDS AND USES THEREOF

#4 | 2025-03-13

US20250084388A1

Chemistry; metallurgy

ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF

#5 | 2024-11-14

US20240374671A1

Human necessities

Activin Type 2 Receptor Binding Proteins and Methods of Making Them

#6 | 2024-11-07

US20240366720A1

Human necessities

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

#7 | 2024-08-29

US20240287196A1

Chemistry; metallurgy

ALK7 Binding Proteins and Uses Thereof

#8 | 2024-05-16

US20240158468A1

Chemistry; metallurgy

TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF

#9 | 2023-12-28

US20230416379A1

Chemistry; metallurgy

ALK7 Binding Proteins and Uses Thereof

#10 | 2023-06-22

US20230190875A1

Human necessities

SINGLE-ARM ACTRIIA AND ACTRIIB HETEROMULTIMERS AND METHODS FOR TREATING PULMONARY HYPERTENSION

#11 | 2022-12-15

US20220396607A1

Chemistry; metallurgy

TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF

#12 | 2022-11-24

US20220372107A1

Chemistry; metallurgy

Multispecific binders of TGFBeta-superfamily ligands and uses thereof

#13 | 2022-11-03

US20220348685A1

Chemistry; metallurgy

ALK7 BINDING PROTEINS AND USES THEREOF

#14 | 2022-09-22

US20220296708A1

Human necessities

ALK1 receptor and ligand antagonists and uses thereof

#15 | 2022-08-18

US20220259297A1

Chemistry; metallurgy

ActRIIa and ALK4 polypeptides for treating kidney fibrosis, inflammation and injury

#16 | 2022-08-04

US20220242956A1

Chemistry; metallurgy

ACTRII-BINDING PROTEINS AND USES THEREOF

#17 | 2022-07-07

US20220211805A1

Human necessities

METHODS FOR TREATING HETEROTOPIC OSSIFICATION

#18 | 2022-03-24

US20220089683A1

Chemistry; metallurgy

BI-AND TRI-FUNCTIONAL FUSION PROTEINS AND USES THEREOF

#19 | 2022-03-24

US20220088142A1

Human necessities

Compositions and methods for treating spinal muscular atrophy

#20 | 2022-01-20

US20220017639A1

Chemistry; metallurgy

METHODS FOR INCREASING THERMOGENIC ADIPOCYTES

#21 | 2022-01-20

US20220017600A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION

#22 | 2021-12-16

US20210388104A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION

#23 | 2021-12-09

US20210380663A1

Chemistry; metallurgy

Binders of TGFβ-superfamily ligands and uses thereof

#24 | 2021-11-25

US20210363502A1

Chemistry; metallurgy

Methods of treatment of muscular dystrophy with ALK4:ActRIIB heteromultimers

#25 | 2021-10-21

US20210324089A1

Chemistry; metallurgy

ALK7 binding proteins and uses thereof

#26 | 2021-10-21

US20210322514A1

Human necessities

Methods and compositions for treating myelofibrosis

#27 | 2021-10-07

US20210308206A1

Human necessities

Activin type 2 receptor binding proteins methods of making them

#28 | 2021-09-30

US20210300991A1

Chemistry; metallurgy

ENDOGLIN POLYPEPTIDES AND USES THEREOF

#29 | 2021-09-09

US20210277082A1

Chemistry; metallurgy

Methods and compositions for increasing red blood cells

#30 | 2021-08-26

US20210261682A1

Chemistry; metallurgy

ACTIVIN-ACTRIIA ANTAGONISTS AND USES FOR TREATING MULTIPLE MYELOMA

#31 | 2021-08-19

US20210253658A1

Chemistry; metallurgy

COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE RED BLOOD CELL LEVELS

#32 | 2021-07-29

US20210230252A1

Chemistry; metallurgy

TGF-BETA RECEPTOR TYPE II VARIANTS AND USES THEREOF

#33 | 2021-07-08

US20210207107A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS

#34 | 2021-06-24

US20210188955A1

Chemistry; metallurgy

METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING SICKLE-CELL DISEASE

#35 | 2021-06-17

US20210177741A1

Human necessities

Methods for treatment of Duchenne muscular dystrophy with follistatin polypeptides

#36 | 2021-06-03

US20210163569A1

Chemistry; metallurgy

ALK4:ActRIIB heteromultimers and uses thereof

#37 | 2021-05-27

US20210155672A1

Chemistry; metallurgy

METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING INEFFECTIVE ERYTHROPOIESIS

#38 | 2021-05-20

US20210147508A1

Chemistry; metallurgy

TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof

#39 | 2021-04-15

US20210107959A1

Chemistry; metallurgy

SINGLE-ARM CO-RECEPTOR FUSION PROTEINS AND USES THEREOF

#40 | 2021-01-28

US20210023174A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#41 | 2021-01-07

US20210002342A1

Chemistry; metallurgy

BMPRII POLYPEPTIDES AND USES THEREOF

#42 | 2020-12-31

US20200405814A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#43 | 2020-12-24

US20200397865A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#44 | 2020-12-24

US20200397863A1

Human necessities

Methods and compositions using GDF15 polypeptides for increasing red blood cells

#45 | 2020-12-17

US20200392233A1

Chemistry; metallurgy

ALK7 binding proteins and uses thereof

#46 | 2020-12-17

US20200390860A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#47 | 2020-12-10

US20200384080A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#48 | 2020-10-15

US20200323955A1

Human necessities

Methods for treating pulmonary hypertension with a ligand binding domain of a TGF-beta type II receptor

#49 | 2020-10-01

US20200306340A1

Human necessities

TGFBETA AND ACTRII ANTAGONISTS FOR USE IN INCREASING IMMUNE ACTIVITY

#50 | 2020-07-02

US20200208124A1

Chemistry; metallurgy

Methods for treating anemia in a subject in need thereof

#51 | 2020-06-25

US20200199548A1

Chemistry; metallurgy

Methods for treating anemia in a subject in need thereof

#52 | 2020-06-25

US20200199547A1

Chemistry; metallurgy

Methods for treating anemia in a subject in need thereof

#53 | 2020-06-25

US20200199546A1

Chemistry; metallurgy

ISOLATED GDF TRAP POLYPEPTIDE

#54 | 2020-06-25

US20200199186A1

Chemistry; metallurgy

Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels

#55 | 2020-06-11

US20200181218A1

Chemistry; metallurgy

Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels

#56 | 2020-06-11

US20200181217A1

Chemistry; metallurgy

Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels

#57 | 2020-05-28

US20200165583A1

Chemistry; metallurgy

ISOLATED GDF TRAP POLYPEPTIDE

#58 | 2020-05-28

US20200164029A1

Human necessities

Endoglin peptides to treat fibrotic diseases

#59 | 2020-05-21

US20200157512A1

Chemistry; metallurgy

Methods and compositions for reducing serum lipids

#60 | 2020-05-21

US20200157182A1

Chemistry; metallurgy

Methods of treating a fibrotic disorder by administering transforming growth factor beta receptor II fusion polypeptides

#61 | 2020-05-14

US20200148788A1

Chemistry; metallurgy

Methods for screening compounds for increasing thermogenic adipocytes

#62 | 2020-04-16

US20200115428A1

Chemistry; metallurgy

Methods and compositions for increasing red blood cells

#63 | 2020-03-19

US20200087406A1

Chemistry; metallurgy

ALK7 binding proteins and uses thereof

#64 | 2020-03-05

US20200071382A1

Chemistry; metallurgy

TGF-BETA SUPERFAMILY HETEROMULTIMERS AND USES THEREOF

#65 | 2020-03-05

US20200071381A1

Chemistry; metallurgy

VARIANTS DERIVED FROM ACTRIIB AND USES THEREFOR

#66 | 2020-02-20

US20200055920A1

Chemistry; metallurgy

Single-arm type I and type II receptor fusion proteins and uses thereof

#67 | 2020-02-20

US20200055919A1

Chemistry; metallurgy

Variant ActRIIB proteins and uses thereof

#68 | 2020-02-13

US20200048355A1

Chemistry; metallurgy

ALK7 ANTAGONISTS AND USES THEREOF

#69 | 2019-12-12

US20190375820A1

Chemistry; metallurgy

ALK7:actriib heteromultimers and uses thereof

#70 | 2019-12-05

US20190365844A1

Human necessities

Methods of increasing muscle mass by administration of activin type 2 receptor antibodies

#71 | 2019-09-19

US20190284257A1

Chemistry; metallurgy

Methods of treating a sclerotic disorder by administering a transforming growth factor beta receptor type II fusion polypeptide

#72 | 2019-08-29

US20190263876A1

Chemistry; metallurgy

Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels

#73 | 2019-07-25

US20190225669A1

Chemistry; metallurgy

TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof

#74 | 2019-07-18

US20190218272A1

Chemistry; metallurgy

ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF

#75 | 2019-04-04

US20190100570A1

Chemistry; metallurgy

ALK4:ActRIIB heteromultimers and uses thereof

#76 | 2019-02-14

US20190048063A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION

#77 | 2019-01-24

US20190023797A1

Chemistry; metallurgy

ACTRIIB BINDING AGENTS AND USES THEREOF

#78 | 2018-11-29

US20180340013A1

Chemistry; metallurgy

Methods and compositions for treatment of disorders with follistatin polypeptides

#79 | 2018-11-15

US20180327477A1

Chemistry; metallurgy

Transforming growth factor beta receptor type II fusion polypeptides

#80 | 2018-11-15

US20180325808A1

Human necessities

Methods for treatment of charcot-marie-tooth disease with follistatin polypeptides

#81 | 2018-11-01

US20180312559A9

Chemistry; metallurgy

METHODS FOR TREATING REFRACTORY ANEMIA WITH RINGED SIDEROBLASTS

#82 | 2018-10-25

US20180305427A1

Chemistry; metallurgy

Method for treating a muscle-related disorder with follistatin-related fusion proteins

#83 | 2018-09-13

US20180258156A1

Chemistry; metallurgy

Endoglin polypeptides and uses thereof

#84 | 2018-08-09

US20180222956A1

Chemistry; metallurgy

Method for treating myelofibrosis comprising administering a transforming growth factor beta type II receptor antagonist

#85 | 2018-08-09

US20180221447A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#86 | 2018-07-26

US20180207236A1

Human necessities

Methods and compositions using GDF15 polypeptides for increasing red blood cells

#87 | 2018-07-05

US20180186851A1

Chemistry; metallurgy

Methods and compositions for increasing red blood cells

#88 | 2018-06-28

US20180179293A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION

#89 | 2018-06-28

US20180179261A1

Chemistry; metallurgy

Transforming growth factor-beta receptor type II fusion polypeptides

#90 | 2018-06-14

US20180163187A1

Chemistry; metallurgy

ALK4.ActRIIB heteromultimers

#91 | 2018-06-14

US20180162954A1

Chemistry; metallurgy

METHODS FOR INCREASING THERMOGENIC ADIPOCYTES

#92 | 2018-03-29

US20180086806A9

Chemistry; metallurgy

BMPRII POLYPEPTIDES AND USES THEREOF

#93 | 2018-03-22

US20180080012A1

Chemistry; metallurgy

Method for producing an ActRIIB-Fc fusion polypeptide

#94 | 2018-02-22

US20180051088A1

Chemistry; metallurgy

ACTRIIB BINDING AGENTS AND USES THEREOF

#95 | 2018-02-22

US20180050089A1

Human necessities

Compositions and methods for treating pulmonary hypertension

#96 | 2018-02-22

US20180050085A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING MYELOFIBROSIS

#97 | 2018-02-08

US20180037622A1

Chemistry; metallurgy

Methods for treating refractory anemia with ringed sideroblasts

#98 | 2017-12-14

US20170354731A1

Human necessities

ALK1 RECEPTOR AND LIGAND ANTAGONISTS AND USES THEREOF

#99 | 2017-11-16

US20170327800A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS

#100 | 2017-10-26

US20170306027A1

Chemistry; metallurgy

ALK7 ANTAGONISTS AND USES THEREOF

InventorID:

10605 ⎘